Ewing's sarcoma: Presentation and management

Journal of Orthopaedic Science

Volumn 6, Issue 4, 2001, Pages 366-371

  Weber, Kristy L ^a   Sim, Franklin H ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Bone; Chemotherapy; Ewing's sarcoma; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER CONTROL; CARCINOGENESIS; CLINICAL FEATURE; CONFERENCE PAPER; EWING SARCOMA; FEMUR; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; PELVIS; PROGNOSIS; RADIOGRAPHY; SPINE;

EID: 0034877092     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007760100034     Document Type: Conference Paper

References (32)

1. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy
2. Multimodal therapy for the management of nonpelvic localized Ewing's sarcoma of bone; Intergroup Study IESS-II
3. Prognostic factors in Ewing's tumor of bone: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group
4. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study
5. Ewing's sarcoma of the proximal femur
6. The Ewing family of tumors - A subgroup of small round cell tumors defined by specific chimeric transcripts
7. Prognostic factors in patients with localized Ewing's sarcoma: The effect on survival of actual received drug dose intensity and of histologic response to induction therapy
8. Vascularized free fibular transfer combined with autografting for the management of fracture nonunions associated with radiation therapy
9. Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: A report from the second Intergroup Study
10. Ewing sarcoma of the pelvis
11. Effects of radiation therapy on skeletal growth in childhood
12. The Ewing family of tumors
13. Adding ifosfamide and etoposide to vincristine, cyclophosphamide, adriamycin, and actinomycin improves outcome in non-metastatic Ewing's and PNET: Update of CCG/POG study
14. Primary Ewing's sarcoma of the spine
15. Ewing's sarcoma. Radiotherapy versus surgery for local control
16. EWS-FLI-1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene
17. Ewing's sarcoma of bone: Clinicopathologic aspects of 303 cases from the Intergroup Ewing's Sarcoma Study
18. Second malignancies after Ewing's sarcoma: Radiation dose-dependency of secondary sarcomas
19. Multimodal therapy for the management of primary, nonmetastastic Ewing's sarcoma of bone: A long-term follow-up of the first Intergroup Study
20. Ewing's sarcoma. Prognostic factors, disease control, and the reemerging role of surgical treatment
21. Significance of surgical margin on the prognosis of patients with Ewing's sarcoma
22. Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities
23. Ewing's sarcoma: Surgical resection as a prognostic factor
24. The role of surgical resection in pelvic Ewing's sarcoma
25. Bone sarcomas linked to radiotherapy and chemotherapy in children
26. Preoperative evaluation and monitoring chemotherapy in patients with highgrade osteogenic and Ewing's sarcoma: Review of current imaging modalities
27. Ewing's sarcoma
28. Ewing sarcoma family of tumors
29. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors
30. Ewing's sarcoma of bone. Experience with 140 patients
31. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma